Use of anticoagulants has been on the rise since blood thinners such as Xarelto were introduced to the market, according to a new study. In 2008, 51% of the patients eligible to be given a blood thinner (usually warfarin) took the drug. That number rose to61% in 2014 after the introductions of Pradaxa and Xarelto.
However, increased use of anticoagulants such as Xarelto may also lead to an increased number of patients suffering from severe blood thinner side effects. Studies have been inconclusive in determining if the new anticoagulants are more effective in preventing blood clots, but several have raised concerns over the safety of Xarelto.
Nearly 2,000 Xarelto adverse events have been reported to the U.S. Food and Drug Administration, including at least 183 deaths. Because Xarelto does not have a natural antidote to reverse its affects, patients could be at an increased risk of internal hemorrhaging and bleeding out. Several patients who have suffered Xarelto side effects have since filed lawsuits.